OptimizeRx Scheduled to Report Q3 2026 Earnings on November 11
OptimizeRx (OPRX) is set to release its third-quarter 2026 financial results following the market close on Wednesday, November 11. The upcoming report comes at a time of projected contraction for the company compared to the previous year. Market analysts have established a consensus earnings per share (EPS) estimate of $0.16, representing a 20% decline year-over-year. Additionally, revenue is expected to reach approximately $21.19 million, which would mark a significant 27.4% decrease compared to the same period last year.
Tickers: $OPRX
Topics: earnings_announcement eps_estimates revenue_estimates
Read the full article at Seeking Alpha
Part of the story OptimizeRx Scheduled to Report Q3 2026 Earnings on November 11 (3 articles)